Evidence map›Paper›PMID 39429872›Full record

ArticleiMeta2024

Chi Zhang, Zhihong Wang, Xu Liu, Xiangpeng Liu, Tong Liu, Yu Feng, Zhengrong Yuan, Zhihao Jia, Yong Zhang

Abstract read
In one paragraph

Article in iMeta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. International journal of molecular sciences · 2026
    Article
  5. Article
  6. iMetaOmics · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Journal of microbiology and biotechnology · 2025
    Article
  14. Article
  15. Acetate Administration Ameliorates Streptozotocin-Induced Hyperglycemia and Adipose Tissue Loss.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  16. Review
  17. Complementary efficacy and molecular insights ofFrontiers in endocrinology · 2025
    Review
  18. Novel probioticFrontiers in microbiology · 2025
    Article
  19. Foods (Basel, Switzerland) · 2024
    Review
  20. iMeta · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chi ZhangCambridge-Suda Genomic Resource Center, Suzhou Medical College Soochow University Suzhou China.
Zhihong WangCambridge-Suda Genomic Resource Center, Suzhou Medical College Soochow University Suzhou China.
Xu LiuCambridge-Suda Genomic Resource Center, Suzhou Medical College Soochow University Suzhou China.
Xiangpeng LiuCambridge-Suda Genomic Resource Center, Suzhou Medical College Soochow University Suzhou China.
Tong LiuInstitute of Pain Medicine and Special Environmental Medicine Nantong University Nantong China.
Yu FengDepartment of Endocrinology The Second Affiliated Hospital of Soochow University Suzhou China.
Zhengrong YuanCollege of Biological Sciences and Technology Beijing Forestry University Beijing China.ORCID 0000-0002-5175-0675
Zhihao JiaCambridge-Suda Genomic Resource Center, Suzhou Medical College Soochow University Suzhou China.ORCID 0000-0001-5525-2721
Yong ZhangCambridge-Suda Genomic Resource Center, Suzhou Medical College Soochow University Suzhou China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease that can lead to severe diabetic complications. While the changes and correlations between gut microbiota and the pathogenesis of T1DM have been extensively studied, little is known about the benefits of interventions on gut bacterial communities, particularly using probiotics, for this disease. In the present study, we reported that the mice surviving after 5 months of streptozotocin (STZ) injection had reduced blood glucose level and recovered gut microbiota with increased

Identifiers

PMID39429872
PMCPMC11487547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.